Matches in Wikidata for { <http://www.wikidata.org/entity/Q76979701> ?p ?o ?g. }
Showing items 1 to 33 of
33
with 100 items per page.
- Q76979701 description "clinical trial" @default.
- Q76979701 description "ensayu clínicu" @default.
- Q76979701 description "klinisch onderzoek" @default.
- Q76979701 description "клінічне випробування" @default.
- Q76979701 name "Adjuvant Dual Anti-HER2 Therapy in Patients With Small, Node-negative, HER2-positive Breast Cancer" @default.
- Q76979701 name "Adjuvant Dual Anti-HER2 Therapy in Patients With Small, Node-negative, HER2-positive Breast Cancer" @default.
- Q76979701 type Item @default.
- Q76979701 label "Adjuvant Dual Anti-HER2 Therapy in Patients With Small, Node-negative, HER2-positive Breast Cancer" @default.
- Q76979701 label "Adjuvant Dual Anti-HER2 Therapy in Patients With Small, Node-negative, HER2-positive Breast Cancer" @default.
- Q76979701 prefLabel "Adjuvant Dual Anti-HER2 Therapy in Patients With Small, Node-negative, HER2-positive Breast Cancer" @default.
- Q76979701 prefLabel "Adjuvant Dual Anti-HER2 Therapy in Patients With Small, Node-negative, HER2-positive Breast Cancer" @default.
- Q76979701 P1132 Q76979701-DBF901CC-FB23-478A-8D59-B929CF4A0CBF @default.
- Q76979701 P1476 Q76979701-B847FF0F-1144-4110-9D4C-DA3F09DF4B40 @default.
- Q76979701 P1813 Q76979701-47BBF583-2B3E-434B-A602-B3E2D1554E57 @default.
- Q76979701 P2899 Q76979701-D4B484DE-D7BB-4788-8E96-DCFEB6977CFD @default.
- Q76979701 P3098 Q76979701-4F495620-60FF-4B9D-AFDF-52EBCADCABAC @default.
- Q76979701 P31 Q76979701-C8FD3497-2D7D-408C-98F0-58C0AA89E4FD @default.
- Q76979701 P4135 Q76979701-12F666B7-8594-47AF-8DFB-969D9784478B @default.
- Q76979701 P580 Q76979701-7BEEB528-E4ED-4A2B-A840-3B2593ED247C @default.
- Q76979701 P582 Q76979701-FB51B0A0-525B-49D3-8BA1-BF6CBE012A23 @default.
- Q76979701 P6099 Q76979701-1DBC0E47-F77C-40B5-AB69-372CDFD02014 @default.
- Q76979701 P8363 Q76979701-8E80AF7B-E701-416C-9CCF-57A655EA9C59 @default.
- Q76979701 P1132 "+60" @default.
- Q76979701 P1476 "Adjuvant Dual Anti-HER2 Therapy in Patients With Tumors < 8mm, Node-negative, HER2-positive Breast Cancer :a Single-group Arm, Open-label, Prospective, Phase 2 Study" @default.
- Q76979701 P1813 "SHERO" @default.
- Q76979701 P2899 "+18" @default.
- Q76979701 P3098 "NCT04158856" @default.
- Q76979701 P31 Q30612 @default.
- Q76979701 P4135 "+70" @default.
- Q76979701 P580 "2020-06-01T00:00:00Z" @default.
- Q76979701 P582 "2023-05-31T00:00:00Z" @default.
- Q76979701 P6099 Q42824440 @default.
- Q76979701 P8363 Q78089383 @default.